US EditionPublished • loading... • Updated
Ozempic Launches in India, with Weight Loss Drug Priced at Under $25 a Week
Novo Nordisk offers Ozempic in three weekly doses starting at ₹2,200 to improve diabetes care amid rising type 2 diabetes and obesity in India.
- Novo Nordisk launched Ozempic in India, introducing the once-weekly injectable approved by the U.S. FDA in 2017 that became a global bestseller.
- India has one of the highest numbers of people with type-2 diabetes globally and ranks second only to China, with rising obesity rates increasing demand for effective local treatments.
- The product is available in three weekly doses priced from Rs 2,200 per week, with monthly equivalents of about Rs 8,800, about Rs 10,170, and about Rs 11,175; Ozempic is approved in India only for diabetes.
- Medical professionals and patients have taken note of the launch, and many Indian medical professionals are aware of the drug's body mass effects when advising diabetic patients.
- As a GLP-1 receptor agonist, Ozempic improves glycaemic control and reduces HbA1c, and local market availability may ease access for many Indians living with diabetes.
Insights by Ground AI
24 Articles
24 Articles
Coverage Details
Total News Sources24
Leaning Left4Leaning Right4Center3Last UpdatedBias Distribution37% Left, 36% Right
Bias Distribution
- 37% of the sources lean Left, 36% of the sources lean Right
37% Left
L 37%
C 27%
R 36%
Factuality
To view factuality data please Upgrade to Premium
